Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 339 followers

Latest posts

Last updated about 21 hours ago

Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug

about 21 hours ago

Werewolf Therapeutics’ hunt for strategic alternatives has ended. Ambros Therapeutics has agreed...

Chutes & Ladders—Neumora shuffles leadership ahead of IND

about 22 hours ago

Joshua Pinto, Ph.D., has been appointed chief executive officer of Neumora Therapeutics...

Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact

about 23 hours ago

As the dust settles on phase 3 data that added $45 billion...

Meet Aletta: The first FDA approved robotic blood draw device

about 23 hours ago

The FDA has approved Vitestro’s Aletta as the first standalone robotic device...

Lilly pens deal with Gateway Labs alumni Amplitude for RNA vaccine platform for infectious disease

about 23 hours ago

Eli Lilly has turned to one of its Gateway Labs residents to...

Chai tees up Bristol Myers Squibb AI antibody discovery collab

about 23 hours ago

A month after Chai Discovery tied up a major $400 million series...

Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling

about 23 hours ago

Pheast Therapeutics may have learned the hard way about the risks of...

Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’

1 day ago

Boehringer Ingelheim has suspended a phase 1 trial of an investigational small...

‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensions

2 days ago

You might assume Chinese biotechs are enduring sleepless nights worrying about whether...

Amgen abandoning $500M+ Crohn’s collab won't derail TScan’s strategy

2 days ago

Amgen is walking away from a Crohn’s disease collaboration with TScan Therapeutics...

Merck and Sarah Cannon team up to boost oncology trial efficiency

3 days ago

Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with...

Trump looks set to tap White House aide Heidi Overton as next FDA commissioner

3 days ago

After three months without a permanent leader in place, President Donald Trump...